Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
December 17, 2008
Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases
Zuping Xia, Christian Knaak, Jian Ma, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 20, 2006
REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors
Martin J I Andrews, George Kontopidis, Campbell McInnes, et al.
ACS Chemical Biology
|
May 23, 2012
Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cells
Matthew A Smith, Campbell McInnes, Ryan M Whitaker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2005
Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design
George Kontopidis, Su-Ying Wu, Daniella I Zheleva, et al.
Molecular Cancer Therapeutics
|
August 1, 2012
Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype
Campbell McInnes, Kara Estes, Merissa Baxter, et al.
Chemistry & Biology
|
February 24, 2006
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design
George Kontopidis, Campbell McInnes, Sravan R Pandalaneni, et al.
Nature Chemical Biology
|
October 10, 2006
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance
Campbell McInnes, Aveek Mazumdar, Mokdad Mezna, et al.
Journal of Medicinal Chemistry
|
February 3, 2022
A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics
Li Zhang, Chen Cheng, Jing Li, et al.
Chemistry & Biology
|
May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors
Campbell McInnes, Shudong Wang, Sian Anderson, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2004
Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors
Shudong Wang, Gavin Wood, Christopher Meades, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
December 17, 2008
Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases
Zuping Xia, Christian Knaak, Jian Ma, et al.
Chembiochem : a European Journal of Chemical Biology
|
October 20, 2006
REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors
Martin J I Andrews, George Kontopidis, Campbell McInnes, et al.
ACS Chemical Biology
|
May 23, 2012
Calpain 10 homology modeling with CYGAK and increased lipophilicity leads to greater potency and efficacy in cells
Matthew A Smith, Campbell McInnes, Ryan M Whitaker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 2005
Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design
George Kontopidis, Su-Ying Wu, Daniella I Zheleva, et al.
Molecular Cancer Therapeutics
|
August 1, 2012
Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype
Campbell McInnes, Kara Estes, Merissa Baxter, et al.
Chemistry & Biology
|
February 24, 2006
Differential binding of inhibitors to active and inactive CDK2 provides insights for drug design
George Kontopidis, Campbell McInnes, Sravan R Pandalaneni, et al.
Nature Chemical Biology
|
October 10, 2006
Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance
Campbell McInnes, Aveek Mazumdar, Mokdad Mezna, et al.
Journal of Medicinal Chemistry
|
February 3, 2022
A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics
Li Zhang, Chen Cheng, Jing Li, et al.
Chemistry & Biology
|
May 5, 2004
Structural determinants of CDK4 inhibition and design of selective ATP competitive inhibitors
Campbell McInnes, Shudong Wang, Sian Anderson, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 21, 2004
Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors
Shudong Wang, Gavin Wood, Christopher Meades, et al.
Page
of 7